Ulrich Otte is Senior Vice President, Finance & Operations for Novo Nordisk Inc. since September 1, 2020. In this role, Mr. Otte provides strategic direction, business insights and corporate governance counsel, and now oversees Commercial Operations, to guide the financial health and commercial execution of the organization.
Joining the U.S. leadership team in 2017, his team has been responsible for supply chain management, procurement and business services, pricing and contract operations, information technology, and commercial effectiveness and data analysis functions. Now, in addition to his financial management responsibilities, he leads an operational team focused on the organization’s efforts to unify operational expertise, drive synergies with Insights & Analytics and IT and increase adoption of technology.
Mr. Otte brings more than 20 years of broad finance and business background ranging from technical accounting and auditing, to managing global transformation projects and leading roles in productions, commercial and Market Access functions.
Prior to joining Novo Nordisk Inc., Mr. Otte was Corporate Vice President, Finance for Novo Nordisk China, leading a diverse team that supported market access, government and public affairs, finance, information technology and procurement, and Hong Kong commercial operations.
Mr. Otte joined Novo Nordisk in 2000 as Financial Controller Corporate Accounting in Copenhagen, Denmark and held roles of increasing financial responsibility in Copenhagen including Corporate Vice President, Product Supply Global Investment and Finance, and Corporate Vice President, Corporate Financial Planning. He began his career as an Audit Manager at PricewaterhouseCoopers.
Mr. Otte holds a Master of Science in Business, Economics and Auditing from Copenhagen Business School.